Cengild Medical Berhad (0243) — Cash Flow Reinvestment Rate
Cengild Medical Berhad (0243) has a Cash Flow Reinvestment Rate of 78.92x as of December 2025, reinvesting RM74.73 Million (capex RM36.98 Million plus investments RM37.75 Million) from operating cash flow of RM947.00K. Check cash flow quality index of Cengild Medical Berhad to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cengild Medical Berhad Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Cengild Medical Berhad across 6 annual periods. Explore debt repayment capacity of Cengild Medical Berhad to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Cengild Medical Berhad (2020–2025)
Year-by-year capital reinvestment analysis for Cengild Medical Berhad. For live market cap and broader valuation context, see 0243 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.28x | RM52.68 Million | RM16.08 Million | RM37.26 Million | ▼ -48.3% |
| 2024 | 6.33x | RM81.91 Million | RM12.94 Million | RM15.73 Million | ▲ +65.1% |
| 2023 | 3.84x | RM52.78 Million | RM13.76 Million | RM2.13 Million | ▲ +11.3% |
| 2022 | 3.45x | RM48.43 Million | RM14.05 Million | RM427.67K | ▲ +1231.9% |
| 2021 | 0.26x | RM3.70 Million | RM14.30 Million | RM1.70 Million | ▲ +11.4% |
| 2020 | 0.23x | RM2.61 Million | RM11.24 Million | RM610.08K | — |